Caring Brands (CABR) Return on Capital Employed (2025 - 2026)
Caring Brands' (CABR) quarterly Return on Capital Employed came in at 375.21% in Q1 2026, down 56.96% quarter-over-quarter from 239.04% in Q4 2025.
Caring Brands (CABR) Return on Capital Employed (2025 - 2026) Analysis & Trends
Caring Brands' Return on Capital Employed history runs 2 years deep, the most recent figure standing at 375.21% for Q1 2026.
- On a quarterly basis, Return on Capital Employed changed N/A year-over-year to 375.21% in Q1 2026; TTM through Mar 2026 was 375.21%, a N/A change from a year earlier, with the FY2025 full-year figure at 202.89%, changed N/A from the prior year.
- Return on Capital Employed eased to 375.21% in Q1 2026 per CABR's latest filing, from 239.04% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 239.04% in Q4 2025 and bottomed at 375.21% in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 8.52% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 27.36% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -1.50% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 21.43% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.46% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 20.04% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.24% |
| 10 | Caring Brands | 20.08 Mn | 21.84 Mn | - | -375.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -375.21% |
| Dec 31, 2025 | -239.04% |